home / stock / pbla / pbla news

PBLA News and Press, Panbela Therapeutics Inc Com From 06/06/23

Stock Information
Company Name: Panbela Therapeutics Inc Com
Stock Symbol: PBLA
Market: NASDAQ
Website: panbela.com
Menu
PBLA PBLA Quote PBLA Short PBLA News PBLA Articles PBLA Message Board
Get PBLA Alerts

News, Short Squeeze, Breakout and More Instantly...
PBLA - Hoth, Zura top healthcare gainers; HTG Molecular, NovoCure lead losers' pack

2023-06-06 10:05:06 ET Gainers: Hoth Therapeutics ( HOTH ) +114% . Zura Bio ( ZURA ) +15% . TScan Therapeutics ( TCRX ) +12% . HealthEquity ( HQY ) +11% . ThermoGenesis ( THMO ) +7% . Losers: HTG Molecular Diagnostics ( ...
PBLA - Connect Biopharma, LAVA top healthcare gainers; Kiora, Kymera among losers

2023-06-02 10:02:23 ET Gainers: Connect Biopharma ( CNTB ) +26% . LAVA Therapeutics ( LVTX ) +19% . Panbela Therapeutics ( PBLA ) +18% . Apollomics ( APLM ) +15% .  Rockwell Medical ( RMTI ) +10% . Losers: Kiora Pharm...

PBLA - Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes

MINNEAPOLIS, June 01, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs announces a poster presentation highlighting the results for CPP...

PBLA - Panbela Therapeutics announces 1-for-30 reverse stock split

2023-05-31 08:47:13 ET Panbela Therapeutics ( NASDAQ: PBLA ) has announced that it will implement the previously announced and stockholder approved 1-for-30 reverse split of its common stock. The reverse stock split will be effective as of the morning of June 1, 2023,...
PBLA - Panbela Announces 1-for-30 Reverse Stock Split Effective June 1, 2023

MINNEAPOLIS, May 31, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will implement the previously announced and stock...

PBLA - Panbela Announces Clinical Trial with Moffitt Cancer Center for Phase I/II Program in STK11 Mutant Non-Small Cell Lung Cancer

MINNEAPOLIS, May 22, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced it has entered into a clinical trial agreement with Moffitt Can...

PBLA - Panbela Therapeutics GAAP EPS of -$0.65

2023-05-04 16:56:27 ET Panbela Therapeutics press release ( NASDAQ: PBLA ): Q1 GAAP EPS of -$0.65. Shares -8.9% . Total cash was $5.2 million as of March 31, 2023. For further details see: Panbela Therapeutics GAAP EPS of -$0.65
PBLA - Panbela Provides Business Update and Reports Q1 2023 Financial Results

MINNEAPOLIS, May 04, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quart...

PBLA - Mastering the Best Penny Stock Swing Trading Techniques 

2023-04-27 06:00:00 ET 3 Top Swing Trading Techniques for Penny Stocks The world of penny stocks offers exciting opportunities for investors seeking high returns through swing trading. These lower-priced stocks, often trading below $5 per share, present a unique landscape where rapid fl...

PBLA - Panbela to Host First Quarter 2023 Earnings Conference Call on May 4, 2023

MINNEAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on May 4, 2023, at 4...
Previous 10 Next 10